The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
about
Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitutionMyeloid Cells as Targets for Therapy in Solid TumorsRegulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinaseRON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cellsIsolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration.Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion.Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.Short-form Ron is a novel determinant of ovarian cancer initiation and progression.The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming.Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics.Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.Role of Recepteur D'origine Nantais on Gastric Cancer Development and ProgressionRON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses.Signaling by MST1Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.The regulatory role of miRNAs on VDR in breast cancer.MST1 binds MST1RExpression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.
P2860
Q24297550-281DE2BA-EDFB-4680-9B9E-05F6159569D6Q26801832-04C583AB-8C65-44A8-84F8-2D9EC452175EQ33703886-E766B317-46E0-4C2D-B3B7-213933C8B23EQ33721142-6F8FEB91-CBF1-4287-B5B9-07FCDDC664E5Q34518350-D7744AF5-2757-4E5B-8906-8A021306771AQ34854941-6DAE41BF-CDD7-40DC-BE00-0260E0DCDEFCQ35146597-63126561-1A8A-4792-9651-CF3EA74AC405Q35556501-65B6766F-B69C-4A48-BAF6-9F75ACC0BBC5Q36140785-CC10475A-235B-4CCF-84A3-D7899186AD5BQ36272118-95F4B6FE-07A3-4C39-AEA6-5B93AC37A79BQ36377994-45498F43-F927-483F-B8D8-9107A6F583F4Q37079634-7ED34370-9B31-41FD-B867-5C1ACB88A6A4Q37164553-9076C3E9-3A76-40E8-9799-8C9198904525Q37645687-9551E6FC-8C89-4D86-B105-C85B2653252EQ38422783-B77F904E-11FC-4E3C-84E2-288EB46C00D8Q39032726-042E6E53-C396-4960-9E35-5C1024769D73Q39271429-717771AC-4D97-4BA9-81A7-8ECA2993E72BQ41962611-897735EF-A1CD-45CB-9C52-0DF5A1963C9AQ42262007-ED18531C-FDC7-46D2-93EF-AC1851CE6DA2Q42542274-ED2FD825-A7A9-4146-9598-E378142D0199Q42723155-1BCFE5EC-1E3D-476F-AE4B-10C1B6A960BDQ42848501-1E6414F6-DBE5-45C6-953F-C9715B229031Q45318129-549BE92A-FA65-414F-B584-F0D215153C03Q46145867-BBC11708-5D00-4719-BDE8-55FAADE07542Q48300428-2DD3B256-5522-429C-B22F-09C0B567FA47Q50298148-EF360564-A236-4A39-904C-6FE413F15420Q50985105-D9E83FB9-DCF6-40EC-B5D9-AED58B4E849DQ53591553-128245DB-FBAB-40DB-A241-0F9E81069522Q54254288-6A169BD4-08BD-44D4-9029-FA9C7B664500Q54314075-712B808B-E491-416E-BEFB-96D2A7EC1945
P2860
The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The macrophage stimulating pro ...... in breast cancer progression.
@ast
The macrophage stimulating pro ...... in breast cancer progression.
@en
The macrophage stimulating pro ...... in breast cancer progression.
@nl
type
label
The macrophage stimulating pro ...... in breast cancer progression.
@ast
The macrophage stimulating pro ...... in breast cancer progression.
@en
The macrophage stimulating pro ...... in breast cancer progression.
@nl
altLabel
The macrophage stimulating pro ...... d in breast cancer progression
@en
prefLabel
The macrophage stimulating pro ...... in breast cancer progression.
@ast
The macrophage stimulating pro ...... in breast cancer progression.
@en
The macrophage stimulating pro ...... in breast cancer progression.
@nl
P2093
P3181
P1433
P1476
The macrophage stimulating pro ...... in breast cancer progression.
@en
P2093
Alana L Welm
Henok Eyob
Kelsi L Kretschmann
Saundra S Buys
P304
P3181
P356
10.2174/138945010792006825
P407
P577
2010-09-01T00:00:00Z